Experimental Therapeutics Clinical Fellowship

Objectives of training:

To learn the key principles in evaluating and managing patients on phase I trials.
To learn and understand the principles of drug development and precision oncology.
To learn and understand the proper conduction and interpretation of clinical research.
To participate in the education of other physicians, staff, and support personnel by preparing and presenting didactic lectures on topics in Hematology/Medical Oncology.
To understand the psycho-social issues involved in the care of cancer patients and to display compassion for patients and family members.

Eligibility:

MBBS
Proficient in English
Inclination towards translational research is preferred
Completed basic training in Internal Medicine and/or achieved a MRCP or local country equivalent. Candidates who are enrolled in a medical oncology training program would be preferred
Registered doctor in home country with good standing
Must not be out of clinical practice for more than 3 years

Training:

Clinical Work

Counsel and attend to the patients enrolled in the phase I trials (all tumor types)
Participate in all activities related to the dedicated phase I unit, e.g. patient review meetings, teleconferences and molecular tumor boards
Option to participate in tumor-specific clinics and ward rounds for enhanced understanding of existing standards of care

Research & Teaching

Fellow will be trained in all aspects of early phase clinical trial management, including GCP, protocol development, administrative aspects and regular interactions with regional and international investigators and pharmaceutical companies.
Participation in Tumor Boards (Type and frequency)

*Trainees will be required to attend the molecular tumor boards and other relevant ones during their rotation plan.

To apply or for more information, please contact pgeu@nccs.com.sg

Available Fellowships:

Phase I/Thoracic Fellowship

One funded fellowship for a year at the Experimental Cancer Therapeutics Unit at National Cancer Centre Singapore.

Be part of a precision oncology programme jointly supported by Division of Clinical Trials and Epidemiological Sciences, Division of Medical Oncology, and Cancer Therapeutics Research Laboratory. Join an interdisciplinary team of physicians, translational scientists, computational biologists, and data scientists to develop novel therapeutics and biomarkers in cancers relevant to Singapore.

The successful candidate will have ample opportunities to gain core competency in running phase I trials, developing protocols, and engaging scientists to establish pharmacodynamic and translational endpoints. There will also be opportunities to engage industry and other regional/ global trialists. Candidate is also expected to participate in multidisciplinary thoracic oncology clinics where neoadjuvant and multi-modality therapies are explored.

The candidate should have:

Medical license to practice in Singapore
MRCP or equivalent (specialist knowledge in oncology/ prior rotation preferred)
Interest in oncology drug development
Suitability for early career medical/clinical oncologist

To apply or for more information, please contact pgeu@nccs.com.sg